Drugs in the Primary and Secondary Prevention of Coronary Artery Disease
Author:
Publisher
Springer Berlin Heidelberg
Link
http://link.springer.com/content/pdf/10.1007/978-3-642-37078-6_55
Reference110 articles.
1. Ansquer JC, Foucher C, Rattier S, Taskinen MR, Steiner G, DAIS Investigators (2005) Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the diabetes atherosclerosis intervention study (DAIS). Am J Kidney Dis 45:485–493
2. Arai H, Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, Daida H, Matsuzaki M, JAPAN-ACS Investigators (2010) More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome – sub-analysis of JAPAN-ACS study. J Atheroscler Thromb 17:1096–1107
3. Armitage J (2007) The safety of statins in clinical practice. Lancet 370:1781–1790
4. Baber NS, Evans DW, Howitt G, Thomas M, Wilson T, Lewis JA, Dawes PM, Handler K, Tuson R (1980) Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia. Br Heart J 44:96–100
5. Ballantyne CM, Nambi V (2004) Apolipoprotein A-I and high-density lipoproteins this the beginning of the era of noninvasive angioplasty?*. J Am Coll Cardiol 44:1436–1438
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3